Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FTFVE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,706
Award facts
- Contract value 100% obligated
- $24,706.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Cosentyx (secukinumab) 300 mg pen 2 ml injections, with a ceiling value of $24,706.05. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.9 million through December 2026. The contract contains no set-aside designation and is scheduled for completion by October 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
Cosentyx is a specialty biologic pharmaceutical used primarily for treating autoimmune and inflammatory conditions, reflecting the federal healthcare system's ongoing pharmaceutical supply needs. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, AmerisourceBergen serves the Defense Health Agency and other federal healthcare entities through its comprehensive pharmaceutical supply vehicle. This delivery order exemplifies the company's role in supporting federal medical procurement requirements through its prime IDC with DLA Troop Support, which enables flexible acquisition of brand-name medications, generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs globally.
Quick answers
Who was awarded contract SPE2DB26FTFVE?
SPE2DB26FTFVE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FTFVE worth?
The government has obligated $24,706 on SPE2DB26FTFVE.
Is contract SPE2DB26FTFVE an order under another contract?
Yes. SPE2DB26FTFVE is a delivery order under SPE2DB25D2204, an indefinite delivery contract.
Was contract SPE2DB26FTFVE competed?
The extent of competition for SPE2DB26FTFVE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award